ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
13.33
-0.15 (-1.11%)
At close: Aug 6, 2026, 4:00 PM EDT
13.75
+0.42 (3.15%)
After-hours: Aug 6, 2026, 6:45 PM EDT
ProMIS Neurosciences Employees
As of December 31, 2025, ProMIS Neurosciences had 11 total employees, including 10 full-time and 1 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$3,692,329
Market Cap
119.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 11 | 3 | 37.50% | 10 | 1 |
| Dec 31, 2024 | 8 | 1 | 14.29% | 7 | 1 |
| Dec 31, 2023 | 7 | 0 | - | 6 | 1 |
| Dec 31, 2022 | 7 | 1 | 16.67% | 6 | 1 |
| Dec 31, 2021 | 6 | 5 | 500.00% | 5 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nautilus Biotechnology | 127 |
| Seer, Inc. | 124 |
| enGene Therapeutics | 82 |
| Vivani Medical | 42 |
| Cue Biopharma | 29 |
| Genelux | 26 |
| Spruce Biosciences | 14 |
| Tiziana Life Sciences | 10 |
PMN News
- 3 days ago - ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - GlobeNewsWire
- 8 days ago - ProMIS Neurosciences price target raised to $69 from $35 at Guggenheim - TheFly
- 9 days ago - ProMIS Neurosciences price target raised to $33 from $20 at Chardan - TheFly
- 9 days ago - ProMIS Neurosciences Transcript: Study result - Transcripts
- 9 days ago - ProMIS Neurosciences Slides: Study result - Filings
- 9 days ago - ProMIS Neurosciences Press release: Study result - Filings
- 9 days ago - ProMIS Neurosciences price target raised to $69 from $35 at Guggenheim - TheFly
- 9 days ago - ProMIS Neurosciences’ PMN310 shows positive result in Alzheimer’s Phase 1b trial - TheFly